ADVERTISEMENTs
-10”-x-5.jpg)
Sandip Patel joins LUNGevity advisory board
With triple board certifications in internal medicine, medical oncology, and hematology, Patel has been recognized for his contributions to cancer research and clinical care.
.png)
Sandip P. Patel / Image- UC San Diego Health
LUNGevity Foundation, a lung cancer research nonprofit, announced the appointment of Indian American oncologist, Sandip Patel, to its scientific advisory board.
Patel, who also serves a professor at the University of California, San Diego (UCSD) brings extensive expertise in immunotherapy and thoracic oncology to the board, the organization said in a statement.
A specialist in immunotherapy and thoracic oncology, Patel expressed his commitment to advancing lung cancer research through his new role. “Having seen the impact of lung cancer on our patients and families, I am honored to be joining LUNGevity’s Scientific advisory board, where we play an increasingly important role in funding research in the leading cause of cancer-related death worldwide,” he stated.
At UCSD Moores Cancer Center, Patel co-leads the Experimental Therapeutics (Phase 1) Program and serves as deputy director of the Sanford Stem Cell Clinical Institute. His work includes research on precision medicine and targeted therapies for lung cancer.
Board chair Charles Rudin highlighted Patel’s expertise in clinical trials and immunotherapy as a valuable addition to the organization’s efforts to improve treatment options for lung cancer patients. “We are honored to announce Dr. Patel as a member of our scientific advisory board. His leadership in clinical trials, immunotherapy, and precision medicine will be instrumental in guiding our initiatives and expanding our research investments,” said Rudin.
With triple board certifications in internal medicine, medical oncology, and hematology, Patel has been recognized for his contributions to cancer research and clinical care. He was named a “Top Doc” in San Diego Magazine’s Physicians of Exceptional Excellence survey and has played a key role in developing novel immunotherapy strategies for lung cancer patients.
Patel earned his medical degree from Baylor College of Medicine while conducting research at MD Anderson Cancer Center. He completed a residency in internal medicine at UCLA Medical Center and a fellowship in medical oncology and hematology at Duke University Medical Center.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login